INBS Financial Statements

Balance sheet, income statement, cash flow, and dividends for Intelligent Bio Solutions Inc (INBS).


$5.98M Market Cap.

As of 09/18/2024 5:00 PM ET (MRY) • Disclaimer

INBS Market Cap. (MRY)


INBS Shares Outstanding (MRY)


INBS Assets (MRY)


Total Assets

$13.78M

Total Liabilities

$5.60M

Total Investments

$0

INBS Income (MRY)


Revenue

$3.54M

Net Income

-$10.16M

Operating Expense

$12.13M

INBS Cash Flow (MRY)


CF Operations

-$9.57M

CF Investing

-$221.43K

CF Financing

$14.56M

INBS Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

INBS Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$13,778,863 (33.07%)

$10,354,612 (-16.17%)

$12,352,173 (-43.49%)

$21,859,369 (782.98%)

Assets Current

$8,534,243 (120.95%)

$3,862,561 (-64.46%)

$10,867,992 (-40.31%)

$18,207,041 (678.10%)

Assets Non-Current

$5,244,620 (-19.21%)

$6,492,051 (337.42%)

$1,484,181 (-59.36%)

$3,652,328 (2591.63%)

Goodwill & Intangible Assets

$4,372,026 (-16.81%)

$5,255,401 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$8,329,350 (119.25%)

$3,798,984 (-42.66%)

$6,624,922 (-56.00%)

$15,057,847 (390.33%)

Property Plant & Equipment Net

$872,594 (-29.44%)

$1,236,650 (215.95%)

$391,408 (0%)

$0 (0%)

Cash & Equivalents

$6,304,098 (310.09%)

$1,537,244 (-81.34%)

$8,238,301 (-34.48%)

$12,573,685 (2842.78%)

Accumulated Other Comprehensive Income

-$712,614 (-23.83%)

-$575,496 (26.98%)

-$788,135 (-19.19%)

-$661,260 (-81.69%)

Deferred Revenue

$2,486,668 (6.36%)

$2,338,057 (-40.50%)

$3,929,355 (-25.12%)

$5,247,212 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$777,537 (-20.65%)

$979,907 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$429,704 (46.23%)

$293,861 (-73.11%)

$1,092,773 (-65.29%)

$3,148,328 (0%)

Trade & Non-Trade Payables

$1,704,568 (-34.69%)

$2,610,028 (60.61%)

$1,625,089 (9.71%)

$1,481,291 (-42.06%)

Accumulated Retained Earnings (Deficit)

-$51,964,332 (-24.29%)

-$41,807,573 (-34.10%)

-$31,175,853 (-36.32%)

-$22,869,803 (-44.45%)

Tax Assets

$525,332 (5.33%)

$498,758 (41.27%)

$353,048 (-65.57%)

$1,025,455 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$871,440 (-34.76%)

$1,335,685 (0%)

$0 (0%)

$0 (0%)

Debt Current

$790,116 (37.02%)

$576,658 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$81,324 (-89.29%)

$759,027 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$5,595,672 (-16.08%)

$6,667,614 (14.83%)

$5,806,402 (-15.27%)

$6,852,748 (-10.89%)

Liabilities Current

$5,450,733 (-7.36%)

$5,883,685 (26.18%)

$4,663,003 (26.62%)

$3,682,650 (-52.11%)

Liabilities Non-Current

$144,939 (-81.51%)

$783,929 (-31.44%)

$1,143,399 (-63.93%)

$3,170,098 (0%)

INBS Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$3,536,557 (77.32%)

$1,994,500 (356.25%)

$437,146 (-77.93%)

$1,980,484 (949.30%)

Cost of Revenue

$1,686,155 (81.27%)

$930,204 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$9,258,496 (15.35%)

$8,026,703 (63.14%)

$4,920,103 (32.32%)

$3,718,263 (51.30%)

Research & Development Expense

$1,673,806 (229.86%)

$507,424 (-86.83%)

$3,853,919 (0.47%)

$3,835,703 (552.10%)

Operating Expenses

$12,133,576 (-11.17%)

$13,659,529 (55.68%)

$8,774,022 (16.15%)

$7,553,966 (148.02%)

Interest Expense

$167,140 (-25.23%)

$223,534 (2865.04%)

$7,539 (-99.31%)

$1,093,608 (138.91%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$10,190,932 (4.44%)

-$10,664,555 (-27.96%)

-$8,333,976 (-18.04%)

-$7,060,201 (-121.12%)

Net Income to Non-Controlling Interests

-$34,173 (-4.07%)

-$32,835 (-17.58%)

-$27,925 (-21.86%)

-$22,915 (21.45%)

Net Income

-$10,156,759 (4.47%)

-$10,631,720 (-28.00%)

-$8,306,051 (-18.03%)

-$7,037,286 (-122.43%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$10,156,759 (4.47%)

-$10,631,720 (-28.00%)

-$8,306,051 (-18.03%)

-$7,037,286 (-122.43%)

Weighted Average Shares

$1,592,746 (58.55%)

$1,004,593 (37.00%)

$733,263 (40.81%)

$520,744 (22.38%)

Weighted Average Shares Diluted

$1,592,746 (58.55%)

$1,004,593 (37.00%)

$733,263 (40.81%)

$520,744 (22.38%)

Earning Before Interest & Taxes (EBIT)

-$9,989,619 (4.02%)

-$10,408,186 (-25.42%)

-$8,298,512 (-39.62%)

-$5,943,678 (-119.65%)

Gross Profit

$1,850,402 (73.86%)

$1,064,296 (143.46%)

$437,146 (-77.93%)

$1,980,484 (949.30%)

Operating Income

-$10,283,174 (18.36%)

-$12,595,233 (-51.08%)

-$8,336,876 (-49.58%)

-$5,573,482 (-95.08%)

INBS Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$221,426 (68.10%)

-$694,142 (21.14%)

-$880,221 (0%)

$0 (0%)

Net Cash Flow from Financing

$14,560,556 (914.44%)

$1,435,323 (0%)

$0 (0%)

$23,402,918 (3089.01%)

Net Cash Flow from Operations

-$9,571,569 (-29.74%)

-$7,377,378 (-119.69%)

-$3,358,034 (70.27%)

-$11,296,477 (-2165.56%)

Net Cash Flow / Change in Cash & Cash Equivalents

$4,766,854 (171.14%)

-$6,701,057 (-54.57%)

-$4,335,384 (-135.69%)

$12,146,412 (5196.41%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

-$189,019 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$5,368 (98.94%)

-$505,123 (-32.85%)

-$380,221 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$14,560,556 (615.31%)

$2,035,549 (0%)

$0 (0%)

$20,108,173 (17374.77%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$707 (98.91%)

-$64,860 (33.22%)

-$97,129 (-343.00%)

$39,971 (394.14%)

Share Based Compensation

$230,496 (-11.35%)

$260,000 (0%)

$0 (0%)

$0 (0%)

Depreciation Amortization & Accretion

$1,213,085 (25.48%)

$966,732 (0%)

$0 (0%)

$0 (0%)

INBS Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

52.30% (-2.06%)

53.40% (-46.60%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-287.20% (46.13%)

-533.10% (71.94%)

-1900.10% (-434.79%)

-355.30% (78.80%)

EBITDA Margin

-248.20% (47.57%)

-473.40% (75.06%)

-1898.30% (-532.56%)

-300.10% (79.07%)

Return on Average Equity (ROAE)

-168.60% (-0.96%)

-167.00% (-96.24%)

-85.10% (-41.36%)

-60.20% (-187.25%)

Return on Average Assets (ROAA)

-84.00% (2.78%)

-86.40% (-58.82%)

-54.40% (-20.09%)

-45.30% (65.60%)

Return on Sales (ROS)

-282.50% (45.86%)

-521.80% (72.51%)

-1898.30% (-532.56%)

-300.10% (79.07%)

Return on Invested Capital (ROIC)

614.90% (172.61%)

-846.90% (40.71%)

-1428.30% (-336.39%)

-327.30% (72.91%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-0.3 (-14.45%)

-0.26 (77.50%)

-1.17 (79.82%)

-5.79

Price to Sales Ratio (P/S)

0.86 (-38.21%)

1.4 (-93.70%)

22.21 (7.19%)

20.72

Price to Book Ratio (P/B)

0.72 (-43.30%)

1.27 (-14.78%)

1.49 (-54.07%)

3.24

Debt to Equity Ratio (D/E)

0.67 (-61.71%)

1.75 (100.34%)

0.88 (92.53%)

0.46 (130.68%)

Earnings Per Share (EPS)

-6.38 (39.70%)

-10.58 (6.62%)

-11.33 (16.69%)

-13.6 (-83.78%)

Sales Per Share (SPS)

2.22 (11.84%)

1.99 (233.05%)

0.6 (-84.33%)

3.8 (756.53%)

Free Cash Flow Per Share (FCFPS)

-6.01 (23.36%)

-7.85 (-53.90%)

-5.1 (76.50%)

-21.69 (-1750.94%)

Book Value Per Share (BVPS)

5.23 (38.29%)

3.78 (-58.14%)

9.04 (-68.75%)

28.92 (337.23%)

Tangible Assets Book Value Per Share (TABVPS)

5.91 (16.35%)

5.08 (-69.87%)

16.84 (-59.87%)

41.98 (621.50%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

0 (0%)

-6

Enterprise Value Over EBITDA (EV/EBITDA)

0.28 (162.95%)

-0.45 (-514.81%)

0.11 (101.86%)

-5.81

Asset Turnover

0.29 (80.86%)

0.16 (458.62%)

0.03 (-77.17%)

0.13 (60.76%)

Current Ratio

1.57 (138.72%)

0.66 (-71.86%)

2.33 (-52.85%)

4.94 (1526.32%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$9,576,937 (-21.50%)

-$7,882,501 (-110.86%)

-$3,738,255 (66.91%)

-$11,296,477 (-2165.56%)

Enterprise Value (EV)

-$2,479,311 (-158.66%)

$4,226,693 (570.17%)

-$898,973 (-102.60%)

$34,523,939

Earnings Before Tax (EBT)

-$10,156,759 (4.47%)

-$10,631,720 (-28.00%)

-$8,306,051 (-18.03%)

-$7,037,286 (-122.43%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$8,776,534 (7.04%)

-$9,441,454 (-13.77%)

-$8,298,512 (-39.62%)

-$5,943,678 (-119.65%)

Invested Capital

-$1,476,554 (-49.75%)

-$986,033 (-79.56%)

-$549,131 (-109.80%)

$5,603,034 (1202.10%)

Working Capital

$3,083,510 (252.56%)

-$2,021,124 (-132.57%)

$6,204,989 (-57.28%)

$14,524,391 (371.46%)

Tangible Asset Value

$9,406,837 (84.48%)

$5,099,211 (-58.72%)

$12,352,173 (-43.49%)

$21,859,369 (782.98%)

Market Capitalization

$5,984,734 (24.25%)

$4,816,536 (-51.14%)

$9,857,116 (-79.80%)

$48,785,561

Average Equity

$6,024,528 (-5.35%)

$6,365,202 (-34.82%)

$9,765,080 (-16.53%)

$11,698,391 (355.30%)

Average Assets

$12,086,324 (-1.80%)

$12,307,737 (-19.37%)

$15,263,674 (-1.82%)

$15,546,153 (547.27%)

Invested Capital Average

-$1,624,549 (-232.18%)

$1,229,006 (111.53%)

$580,998 (-68.01%)

$1,816,154 (711.01%)

Shares

3,117,049 (79.91%)

1,732,567 (132.72%)

744,495 (20.25%)

619,106 (29.64%)